Cell-Dyn Ruby System
by Abbott Laboratories 510(k)
Active
510(k) K061667
Regulatory status
Recall ongoing. 6 ongoing FDA recalls. See recalls
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK061667 | Date10 Jul 2006 | StatusActive |
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not known
- Not covered
United States — FDA 510(k) Active
Recalls
-
- Ongoing Z-1654-2025
- Ongoing Z-1655-2025
- Ongoing Z-1652-2025
- Ongoing Z-1656-2025
- Ongoing Z-1653-2025
When expired reagents are scanned or manually entered, the system will change the expiration date to current or future date without notifying user that an expired reagent is being used. Use of expired reagents is against the guidelines of the Operator's Manual.
-
- Ongoing Z-0604-2024
The devices contain a dry natural rubber (latex) subcomponent, which are not labeled as containing dry natural rubber(latex).
-
- Terminated Z-1438-2017
The Pump Relay Printed Circuit Board Assembly (PCBA) used in the CELL-DYN Ruby instrument may prematurely fail and lead to instrument stoppage
-
- Terminated Z-2019-2011
The Nylon Washer has an outer diameter which is undersized resulting in the inability to generate patient results.
-
- Terminated Z-2352-2010
Epoxy holding the two parts of the waste reservoir together fails, potentially resulting in biohazardous fluid leaks.
-
- Terminated Z-1398-2009
Burn Risk-- when power is cycled to the instrument, there is a possibility that the Mixer Motor Assembly may reach 100 degrees Celsius (212 degrees Fahrenheit ). If the customer touches the motor, burns may occur.
-
- Terminated Z-1064-2009
Carryover failures in software revisions 1.0ML and 2.0ML result in elevated PLT background count.
-
- Terminated Z-0565-2007
Results for tests of RBC, MCV, RDW, MPV and PLT may be falsely elevated or falsely decreased when the Cell Dyn Diluent/Sheath reagent is used with Cell-Dyn 4000, Ruby and Sapphire systems.
Specification
- 510(k) Number
- FDA Product Code
- GKZ
- Device Class
- Class II
- Regulation
- 21 CFR Part 864.5220
- Advisory Committee
- Hematology
- FDA Decision
- SESE Substantially Equivalent